Risk Factors for Renal Dysfunction in Type 2 Diabetes: U.K. Prospective Diabetes Study 74 Ravi Retnakaran, Carole A Cull, Kerensa I Thorne, Amanda I Adler,

Slides:



Advertisements
Similar presentations
A Nature Cure to High Blood Lipid Level -Hydrogen Rich Water
Advertisements

Dinkar Kaw, M.D., Division of Nephrology
DIABETES AND THE KIDNEYS
Proteinuria as a Surrogate Outcome in Chronic Kidney Disease Early Diabetes – Microalbuminuria (MA) Type 2 Diabetes in American Indians Robert G Nelson,
Chapter 1: CKD in the General Population 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Canadian Diabetes Association Clinical Practice Guidelines Chronic Kidney Disease in Diabetes Chapter 29 Phil McFarlane, Richard E. Gilbert, Lori MacCallum,
1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.
Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States Ian H. de Boer, MD, MS, Tessa C. Rue, MS, Yoshio N. Hall, MD, Patrick.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
A retrospective cohort study of Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life Andrew V White,
Mugendi AG, BPharm, MPharm (Clin Pharm). Comparison of the effects of losartan and enalapril on renal function in adults with chronic kidney disease at.
ADVICE. Advice Strongly advise adherence to diet and medication Smoking cessation, exercise, weight reduction Ensure diabetes education and advise Diabetes.
Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Lesley Stevens MD Tufts-New England Medical Center
Effects of Low-Fat Dairy Consumption on Markers of Low- Grade Systemic Inflammation and Endothelial Function in Overweight and Obese Subjects: An Intervention.
Predictors of 5-year mortality of 1,323 patients newly diagnosed with clinical type 2 diabetes in general practice With special emphasis on self-rated.
Obesity M.A.Kubtan MD - FRCS M.A.Kubtan1. 2  Pulmonary Disease  Fatty Liver Disease  Orthopedic Disorders  Gallbladder Disease  Psychological Impact.
METABOLIC Syndrome: a Global Perspective
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.
The National Kidney Foundation’s Kidney Early Evaluation Program TM “The Greater New York Experience” Ellen H. Yoshiuchi, MPS Division Program Director.
0902CZR01NL537SS0901 RENAAL Altering the Course of Renal Disease in Hypertensive Patients with Type 2 Diabetes and Nephropathy with the A II Antagonist.
Shadi Al-Ahmadi. The Presentation will include: Hypertension Dyslipidemia CVD Type 2 Diabetes-Associated Retinopathy Diabetic Periphral Neuropathy Diabetic.
Diabetic Nephropathy in the Adolescent Age Group Henry Rodriguez, M.D. Associate Professor of Pediatrics Indiana University School of Medicine Director,
Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less than 75 Years of Age Hiromichi Suzuki, Tsutomu Inoue,Tomohiro.
FDA Endocrinologic and Metabolic Drugs Advisory Committee 1st June 2008 Rury Holman Clinical outcomes with anti-diabetic drugs: What we already know.
Diabetes National Diabetes Control Programme
Proteinuria as a surrogate outcome in CKD UKPDS Rudy Bilous Middlesbrough, UK.
Kimberly Dunbar, PA-S2 Follow-up of Cardiovascular Risk Markers in Hypertensive Patients Treated with Irbesartan: Results of the i-SEARCH Plus Registry.
Dr. I. Selvaraj Indian Railways Medical Service B.Sc., M.B.B.S., M.D.,D.P.H., D.I.H., PGCHFW ( NIHFW,New Delhi)., Life member of Indian Association of.
Insulin Resistance Progression to Diabetes. Hypertension: BP >140/90 Dyslipidemia: ◦TG >150 mg/dL (1.7 mmol.L) ◦HDL-C
2-4. Estimated Renal Function Estimated GFR = 1.8 x (Cs) x (age) Cockcroft-Gault eq. – Estimated creatine clearance (mL/min) = (140 – age x body weight,
Section III. Assessment of Overall Cardiovascular Risk in Hypertensive Patients 2015 Canadian Hypertension Education Program Recommendations.
Prevention of complications of endocrine disorders R.Fielding Department of Community Medicine, HKU.
Chapter 1: CKD in the General Population 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 2: Identification and Care of Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
Treatment of Hypertension in Adults With Diabetes DR AMAL HARFOUSH.
Lab (5): Renal Function test (RFT) (Part 2) T.A Nouf Alshareef T.A Bahiya Osrah KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab.
مقاربة مريض الكلية السكرية د. منى دكر اختصاصية بأمراض الغدد الصم و السكري.
1 به نام خدا. Epidemiology of chronic kidney disease 2.
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease S Bianchi, R Bigazzi and VM Campese Kidney.
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Sickle Cell Trait With Chronic Kidney.
1 Effect of Ramipril on the Incidence of Diabetes The DREAM Trial Investigators N Engl J Med 2006;355 FM R1 윤나리.
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
Changes in the concentration of serum C-peptide in type 2 diabetes during long-term continuous subcutaneous insulin infusion therapy Department of Internal.
Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients Giovanni Targher, Lorenzo Bertolini, Felice Poli,
Powered by Infomedica Infomedica Conference Coverage* of 26 th European Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13,
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
Diabetes Fact Sheet in Korea 2016.
From ESH 2016 | LB 3: Davide Agnoletti, MD
2017 Annual Data Report Healthy People 2020.
Chapter 1: CKD in the General Population
Jagadesh M ,SURYA NARAYANA J, JAYAPRAKASH, NRRAU
برنامه غربالگری و بیماریابی بیماری های قلبی عروقی و عوامل خطر آن در استان فارس معاونت بهداشتی دانشگاه علوم پزشکی شیراز واحد غیر واگیر برنامه قلب و عروق.
So What is Albuminuria? An elevated urinary albumin excretion is a marker of endothelial dysfunction that symbolizes the kidney’s way to translate the.
Diabetes Fact Sheet in Korea 2016.
The percentage of subjects with de novo development of renal function impairment (GFR
Chapter 1: CKD in the General Population
به نام خدا.
Hypertension evaluation
Nuhad Ismail, Bryan Becker, Piotr Strzelczyk, Eberhard Ritz 
American Journal of Kidney Diseases
Relative risk of a major coronary heart disease event (myocardial infarction incidence, fatal coronary heart disease, or coronary revascularization) for.
Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension  Julian Segura, Carlos Campo, Luis M. Ruilope  Kidney.
Atrasentan reduces albuminuria in diabetic apoE KO mice.
Friends, social networks, and progressive chronic kidney disease
Hazard ratios, with 95% confidence intervals as floating absolute risks, as estimate of association between category of updated mean haemoglobin A1c concentration.
Presentation transcript:

Risk Factors for Renal Dysfunction in Type 2 Diabetes: U.K. Prospective Diabetes Study 74 Ravi Retnakaran, Carole A Cull, Kerensa I Thorne, Amanda I Adler, Rury R Holman Diabetes. Jun Vol. 55

BACKGROUND Type 2 diabetes : leading cause of ESRD In the UKPDS, 24.9% developed microalbuminuria But only 0.8% developed ESRD Classical paradigm : annual transitional rate: 2-3% NormoalbuminuriaMicroalbuminuria MacroalbuminuriaESRD

OBJECTIVE To identify clinically evident risk factors that are associated with the subsequent development of renal dysfunction

METHODS UKPDS : 5,102 with newly diagnosed type 2 diabetes between 1977 and 1991 Exclusion criteria  myocardial infarction or stroke  severe vascular disease  uncontrolled hypertension  proliferative or preproliferative retinopathy  plasma creatinine ≥175 µmol/l (=3.15mg/dl)  treatment with systemic steroids  severe previous illness

METHODS Renal outcomes  Microalbuminuria : urinary albumin concentration mg/l  Macroalbuminuria : urinary albumin concentration ≥300 mg/l  Reduced glomerular filtration rate : : estimated creatinine clearance ≤60 ml/min  Doubling of baseline plasma creatinine AlbuminuriaRenal impairment

RESULTS

METHODS

RESULTS 1,544 of 4031 (38%)1,449 of 5,032 (29%)

RESULTS In 4,006 patients with the requisite data for both outcomes, 1,534 (38%) developed albuminuria 1,132 (28%) developed renal impairment 557 (14%) developed both conditions Of the 1,534 patients who developed albuminuria, 977 (64%) no renal impairment 372 (24%) albuminuria → renal impairment 12% renal impairment before developing albuminuria Of the 1,132 patients who developed renal impairment, 575 (51%) no albuminuria 185 (16%) albuminuria → renal impairment 33% developed albuminuria before developing renal impairment

DISCUSSION Over 15 years after type 2 DM diagnosis in UKPDS, 38% developed albuminuria 29% developed renal impairment WESDR study  In renal impairment patients, 61% : no albuminuria beforehand 39% : never developed albuminuria during the study  In albuminuria patients, : only 24% subsequently developed renal impairment Risk factors for both albuminuria and renal impairment  SBP  urinary albumin excretion  plasma creatinine  Indian-Asian ethnicity

DISCUSSION Albuminuria : a marker of nephropathic risk in type 2 diabetes However, microalbuminuria alone : may not high risk factor  stabilization of microalhuminuria without progression and regression of albuminuria  underlying renal structural lesions  Third National Heath and Nutrition Examination Survey : 30% - neither albuminuria nor retinopathy Identification of other risk factors is needed Distinction between risk factors for albuminuria and for renal impairment

DISCUSSION Most highly risk factors for albuminuria  urinary albumin  systolic blood pressure  plasma triglycerides  Indian-Asian ethnicity

DISCUSSION Plasma triglycerides  Elevated triglyceride-to-HDL ratio : independently associated with progression of microalbuminuria  Fasting TG : a strong independent determinant of both microalbuminuria and macroalbuminuria Indian-Asian ethnicity  Increased incidence of renal failure in U.K. Indian-Asian patients  In cross sectional studies, higher prevalence of microalbuminuria in Indian Asians

DISCUSSION Previous prospective studies : several other risk factors for incident albuminuria age, male sex. duration of diabetes, smoking, obesity, and the presence of retinopathy white cell count both type 2 diabetes and atherosclerotic vascular disease : states of chronic low-grade inflammation activated leukocytes : nephrotoxic cytokines

DISCUSSION The most highly associated risk factors for creatinine clearance ≤60 : plasma creatinine, systolic blood pressure, age, female, height, decreased waist circumference Sex and waist circumference : paradoxical associations  male and increased central obesity → albumiiutria  female and decreased waist circumference → renal impairment

CONCLUSION 15 years from diagnosis of type 2 diabetes, nearly 40% developed albuminuria nearly 30% developed renal impairment Risk factors for both albuminuria & renal impairment : systolic blood pressure, Indian-Asian ethnicity, urinary albumin excretion, plasma creatinine Albuminuria and renal impairment are not inexorably linked in type 2 diabetes